OS Therapies Incorporated (OSTX) is a publicly traded Healthcare sector company. As of August 21, 2026, OSTX trades at $1.55 with a market cap of $67.34M and a P/E ratio of -1.60. OSTX moved -1.28% today. Year to date, OSTX is +18.66%; over the trailing twelve months it is -33.75%. Its 52-week range spans $1.12 to $7.00. Analyst consensus is strong buy with an average price target of $8.67. Rallies surfaces OSTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
OSTX financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. OSTX recently traded at $1.55. Market cap is $67.34M. P/E ratio is -1.60. Revenue is $0.
| Metric | Value |
|---|---|
| Price | $1.55 |
| Market Cap | $67.34M |
| P/E Ratio | -1.60 |
| EPS | $-0.98 |
| Dividend Yield | 0.00% |
| 52-Week High | $7.00 |
| 52-Week Low | $1.12 |
| Volume | 348.90K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-28.75M |
| Gross Margin | 0.00% |
3 analysts cover OSTX: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.67.